Search research articles
Contact Us
Filters
Showing results (151-160 of 166) with videos related to
Page
of 17
Sort By:
Statistics in Biopharmaceutical Research
|
June 30, 2021
Efficient Adaptive Designs for Clinical Trials of Interventions for COVID-19
Nigel Stallard, Lisa Hampson, Norbert Benda, et al.
Journal of the American Society of Nephrology : JASN
|
December 16, 2017
A Randomized Trial of Bortezomib in Late Antibody-Mediated Kidney Transplant Rejection
Farsad Eskandary, Heinz Regele, Lukas Baumann, et al.
Therapeutic Innovation & Regulatory Science
|
November 24, 2025
In Silico Clinical Trials in Drug Development: A Systematic Review
Bohua Chen, Lucia Chantal Schneider, Christian Röver, et al.
Frontiers in Medicine
|
February 10, 2022
Sex Differences in Kidney Transplantation: Austria and the United States, 1978-2018
Sebastian Hödlmoser, Teresa Gehrig, Marlies Antlanger, et al.
Vaccine
|
June 27, 2026
A prematurely terminated phase 2, randomised trial to evaluate immunogenicity and reactogenicity of a single versus two-dose primary vaccination regimen of the mRNA vaccine BNT162b2 in previously SARS-CoV-2 infected children 5-11 years old (CoVacc trial)
Cristina Prat-Aymerich, Lusine Yeghiazaryan, Rishi Delan Pathirana, et al.
Nutrients
|
March 28, 2026
Extremity Ultrasound vs. Computed Tomography at the Third Lumbar Vertebra Level for Assessing the Subcutaneous Adipose Tissue-to-Muscle Ratio
Arabella Fischer-Hammerschmied, Maximilian Pesta, Anatol Hertwig, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 2, 2005
Prospective, randomized, multicenter, double-blind placebo-controlled trial comparing adjuvant interferon alfa and isotretinoin with interferon alfa alone in stage IIA and IIB melanoma: European Cooperative Adjuvant Melanoma Treatment Study Group
Erika Richtig, H Peter Soyer, Martin Posch, et al.
Orphanet Journal of Rare Diseases
|
November 14, 2018
Applicability and added value of novel methods to improve drug development in rare diseases
Marian Mitroiu, Katrien Oude Rengerink, Caridad Pontes, et al.
Clinical Pharmacology and Therapeutics
|
March 26, 2024
Regulatory Issues of Platform Trials: Learnings from EU-PEARL
Quynh Lan Nguyen, Katharina Hees, Sabina Hernandez Penna, et al.
Orphanet Journal of Rare Diseases
|
October 26, 2018
Recent advances in methodology for clinical trials in small populations: the InSPiRe project
Tim Friede, Martin Posch, Sarah Zohar, et al.
Page
of 17
Search research articles
Search
Showing results (151-160 of 166) with videos related to
Sort By:
Page
of 17
Statistics in Biopharmaceutical Research
|
June 30, 2021
Efficient Adaptive Designs for Clinical Trials of Interventions for COVID-19
Nigel Stallard, Lisa Hampson, Norbert Benda, et al.
Journal of the American Society of Nephrology : JASN
|
December 16, 2017
A Randomized Trial of Bortezomib in Late Antibody-Mediated Kidney Transplant Rejection
Farsad Eskandary, Heinz Regele, Lukas Baumann, et al.
Therapeutic Innovation & Regulatory Science
|
November 24, 2025
In Silico Clinical Trials in Drug Development: A Systematic Review
Bohua Chen, Lucia Chantal Schneider, Christian Röver, et al.
Frontiers in Medicine
|
February 10, 2022
Sex Differences in Kidney Transplantation: Austria and the United States, 1978-2018
Sebastian Hödlmoser, Teresa Gehrig, Marlies Antlanger, et al.
Vaccine
|
June 27, 2026
A prematurely terminated phase 2, randomised trial to evaluate immunogenicity and reactogenicity of a single versus two-dose primary vaccination regimen of the mRNA vaccine BNT162b2 in previously SARS-CoV-2 infected children 5-11 years old (CoVacc trial)
Cristina Prat-Aymerich, Lusine Yeghiazaryan, Rishi Delan Pathirana, et al.
Nutrients
|
March 28, 2026
Extremity Ultrasound vs. Computed Tomography at the Third Lumbar Vertebra Level for Assessing the Subcutaneous Adipose Tissue-to-Muscle Ratio
Arabella Fischer-Hammerschmied, Maximilian Pesta, Anatol Hertwig, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 2, 2005
Prospective, randomized, multicenter, double-blind placebo-controlled trial comparing adjuvant interferon alfa and isotretinoin with interferon alfa alone in stage IIA and IIB melanoma: European Cooperative Adjuvant Melanoma Treatment Study Group
Erika Richtig, H Peter Soyer, Martin Posch, et al.
Orphanet Journal of Rare Diseases
|
November 14, 2018
Applicability and added value of novel methods to improve drug development in rare diseases
Marian Mitroiu, Katrien Oude Rengerink, Caridad Pontes, et al.
Clinical Pharmacology and Therapeutics
|
March 26, 2024
Regulatory Issues of Platform Trials: Learnings from EU-PEARL
Quynh Lan Nguyen, Katharina Hees, Sabina Hernandez Penna, et al.
Orphanet Journal of Rare Diseases
|
October 26, 2018
Recent advances in methodology for clinical trials in small populations: the InSPiRe project
Tim Friede, Martin Posch, Sarah Zohar, et al.
Page
of 17